Replies to post #393417 on Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

Thanks.

For (I think) the first time, the site now has the full protocol, which can be seen here:

https://clinicaltrials.gov/ProvidedDocs/97/NCT04784897/Prot_000.pdf

It provides at least a clue as to why the death rate in all arms was comparatively low:

Exclusion criteria:

"Requiring invasive mechanical ventilation and/or extracorporeal membrane
oxygenation (ECMO) at the time of randomization.
• Has explicitly expressed the wish not to receive intensive care support (Do not
resuscitate or Do not intubate order) should this become necessary.
• In the opinion of the investigator, progression to death is imminent and inevitable
within the next 72 hours, irrespective of the provision of treatment, such as rapidly
progressive multiorgan failure."

[StockJumper25]

Thanks for this update and link: If you pull up other outcomes analysis there appears to be some significant changes (must do a side-by-side comparison) to the clinical documentation.
More favorable as far as we can tell, on the same data taken. I thought that there were more deaths due to the conditions of health status for subjects.

I could be reading the data wrong.

Thanks!